MabVax Therapeutics
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
You can watch MBVXQ and buy or sell other stocks, ETFs, and their options commission-free!About MBVXQ
MabVax Therapeutics Holdings, Inc. is a clinical stage biopharmaceutical company, which focuses on discovering and developing innovative vaccine and monoclonal antibody-based therapeutics for the diagnosis and treatment of cancer. The company was founded on July 8, 2014 and is headquartered in San Diego, CA.
CEOJohn David Hansen
CEOJohn David Hansen
Employees—
Employees—
HeadquartersClinton, Arkansas
HeadquartersClinton, Arkansas
Founded2014
Founded2014
Employees—
Employees—
MBVXQ Key Statistics
Market cap216.90K
Market cap216.90K
Price-Earnings ratio—
Price-Earnings ratio—
Dividend yield—
Dividend yield—
Average volume976.70
Average volume976.70
High today—
High today—
Low today—
Low today—
Open price—
Open price—
Volume0.00
Volume0.00
52 Week high$0.139
52 Week high$0.139
52 Week low$0.0037
52 Week low$0.0037
Stock Snapshot
The current MabVax Therapeutics(MBVXQ) stock price is $0.02, with a market capitalization of 216.9K.
On 2025-12-11, MabVax Therapeutics(MBVXQ) shares started trading at —, with intraday highs of — and lows of —.
Trading activity shows a volume of 0, compared to an average daily volume of 976.7.
Over the past 52 weeks, MabVax Therapeutics(MBVXQ) stock has traded between a high of $0.14 and a low of $0.00.
Over the past 52 weeks, MabVax Therapeutics(MBVXQ) stock has traded between a high of $0.14 and a low of $0.00.